🇺🇸 FDA
Patent

US 6921527

Composition for pulmonary administration comprising a drug and a hydrophobic amino acid

expired A61KA61K31/7088A61K31/727

Quick answer

US patent 6921527 (Composition for pulmonary administration comprising a drug and a hydrophobic amino acid) held by Nektar Therapeutics expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/7088, A61K31/727, A61K38/1793, A61K38/215